Literature DB >> 17360388

Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice.

Apoorva Bhatt1, Nagatoshi Fujiwara, Kiranmai Bhatt, Sudagar S Gurcha, Laurent Kremer, Bing Chen, John Chan, Steven A Porcelli, Kazuo Kobayashi, Gurdyal S Besra, William R Jacobs.   

Abstract

Mycobacterium tuberculosis, the causative agent of tuberculosis, has two distinguishing characteristics: its ability to stain acid-fast and its ability to cause long-term latent infections in humans. Although this distinctive staining characteristic has often been attributed to its lipid-rich cell wall, the specific dye-retaining components were not known. Here we report that targeted deletion of kasB, one of two M. tuberculosis genes encoding distinct beta-ketoacyl- acyl carrier protein synthases involved in mycolic acid synthesis, results in loss of acid-fast staining. Biochemical and structural analyses revealed that the DeltakasB mutant strain synthesized mycolates with shorter chain lengths. An additional and unexpected outcome of kasB deletion was the loss of ketomycolic acid trans-cyclopropanation and a drastic reduction in methoxymycolic acid trans-cyclopropanation, activities usually associated with the trans-cyclopropane synthase CmaA2. Although deletion of kasB also markedly altered the colony morphology and abolished classic serpentine growth (cording), the most profound effect of kasB deletion was the ability of the mutant strain to persist in infected immunocompetent mice for up to 600 days without causing disease or mortality. This long-term persistence of DeltakasB represents a model for studying latent M. tuberculosis infections and suggests that this attenuated strain may represent a valuable vaccine candidate against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360388      PMCID: PMC1829279          DOI: 10.1073/pnas.0608654104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.

Authors:  R A Slayden; C E Barry
Journal:  Tuberculosis (Edinb)       Date:  2002       Impact factor: 3.131

2.  Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain deviod of methoxy- and ketomycolates.

Authors:  Premkumar Dinadayala; Francoise Laval; Catherine Raynaud; Anne Lemassu; Marie-Antoinette Laneelle; Gilbert Laneelle; Mamadou Daffe
Journal:  J Biol Chem       Date:  2002-12-06       Impact factor: 5.157

3.  The role of lipids in acid-fastness of mycobacteria.

Authors:  T Murohashi; E Kondo; K Yoshida
Journal:  Am Rev Respir Dis       Date:  1969-05

4.  Protein-protein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability.

Authors:  Romain Veyron-Churlet; Olivier Guerrini; Lionel Mourey; Mamadou Daffé; Didier Zerbib
Journal:  Mol Microbiol       Date:  2004-12       Impact factor: 3.501

5.  The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2.

Authors:  K M George; Y Yuan; D R Sherman; C E Barry
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

6.  Gas-chromatographic analysis of mycolic acid cleavage products in mycobacteria.

Authors:  G O Guerrant; M A Lambert; C W Moss
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

Review 7.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

8.  The nature of mycobacterial acid-fastness.

Authors:  K Harada
Journal:  Stain Technol       Date:  1976-09

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Distribution of C22-, C24- and C26-alpha-unit-containing mycolic acid homologues in mycobacteria.

Authors:  K Kaneda; S Imaizumi; I Yano
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

View more
  78 in total

1.  Structure of the sensor domain of Mycobacterium tuberculosis PknH receptor kinase reveals a conserved binding cleft.

Authors:  Alexandra Cavazos; Daniil M Prigozhin; Tom Alber
Journal:  J Mol Biol       Date:  2012-06-20       Impact factor: 5.469

2.  Phosphorylation of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA regulates mycolic acid biosynthesis.

Authors:  Romain Veyron-Churlet; Isabelle Zanella-Cléon; Martin Cohen-Gonsaud; Virginie Molle; Laurent Kremer
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

3.  Identification and characterization of two novel methyltransferase genes that determine the serotype 12-specific structure of glycopeptidolipids of Mycobacterium intracellulare.

Authors:  Noboru Nakata; Nagatoshi Fujiwara; Takashi Naka; Ikuya Yano; Kazuo Kobayashi; Shinji Maeda
Journal:  J Bacteriol       Date:  2007-11-16       Impact factor: 3.490

4.  ACCase 6 is the essential acetyl-CoA carboxylase involved in fatty acid and mycolic acid biosynthesis in mycobacteria.

Authors:  Daniel G Kurth; Gabriela M Gago; Agustina de la Iglesia; Bernardo Bazet Lyonnet; Ting-Wan Lin; Héctor R Morbidoni; Shiou-Chuan Tsai; Hugo Gramajo
Journal:  Microbiology (Reading)       Date:  2009-05-07       Impact factor: 2.777

5.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

6.  Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.

Authors:  Daniel Barkan; Vivek Rao; George D Sukenick; Michael S Glickman
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

7.  The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.

Authors:  Romain Veyron-Churlet; Virginie Molle; Rebecca C Taylor; Alistair K Brown; Gurdyal S Besra; Isabelle Zanella-Cléon; Klaus Fütterer; Laurent Kremer
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

8.  Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis.

Authors:  Olga Danilchanka; Claudia Mailaender; Michael Niederweis
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

9.  Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin.

Authors:  Sylvia R Luckner; Carl A Machutta; Peter J Tonge; Caroline Kisker
Journal:  Structure       Date:  2009-07-15       Impact factor: 5.006

10.  An in vivo platform for rapid high-throughput antitubercular drug discovery.

Authors:  Kevin Takaki; Christine L Cosma; Mark A Troll; Lalita Ramakrishnan
Journal:  Cell Rep       Date:  2012-07-20       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.